Mitochondrial DNA polymorphisms/haplogroups in hereditary spastic paraplegia

Area of Science:

• Genetics
• Neuroscience
• Mitochondrial Biology

Background:

• Mitochondrial dysfunction is implicated in spastic paraplegia pathogenesis.
• Hereditary spastic paraplegia genes encode mitochondrial proteins, and clinical features overlap with mitochondrial DNA (mtDNA) mutation syndromes.

Purpose of the Study:

• To investigate the association between common mtDNA polymorphisms and spastic paraplegia.
• To explore the role of mtDNA haplogroups and specific polymorphisms in disease risk and phenotype modification.

Main Methods:

• Determined ten common European haplogroup-defining mtDNA polymorphisms in 424 spastic paraplegia patients.
• Analyzed genotype-phenotype correlations, including disease presentation (pure vs. complicated) and known genetic mutations (SPG3A, SPG4, SPG7).

Main Results:

• A rare haplogroup was associated with spastic paraplegia in patients negative for SPG3A, SPG4, or SPG7 mutations.
• The mtDNA polymorphism 10398G was more prevalent in patients with a pure phenotype compared to a complicated one.
• This specific polymorphism has prior associations with other neurodegenerative diseases.

Conclusions:

• Certain mtDNA polymorphisms may contribute to spastic paraplegia development.
• mtDNA variants could act as modifying factors influencing the clinical phenotype of spastic paraplegia.